The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options / PDMR dealing

14 May 2021 10:11

RNS Number : 6827Y
Sopheon PLC
14 May 2021
 

For Immediate Release

 

 

 

 

SOPHEON PLC

("Sopheon" or "the Company")

 

Grant of Options / PDMR dealing

 

Sopheon announces that the Company has granted options over ordinary shares of 20 pence each in the share capital of the Company ("Options") to three executive directors.

 

Gregory Coticchia, the recently appointed CEO has been granted 80,000 Options at an exercise price of 845p, being the mid-market closing price on AIM on 13 May 2021, the last business day prior to the grant. Including this grant, the total number of Options held by him is 100,000.

 

Andrew Michuda, Executive Chairman and Arif Karimjee, CFO have been granted 165,000 and 43,350 Options respectively at an exercise price of 900p. Including this grant, the total number of Options held by each is 320,000 and 93,000 respectively.

 

The Options granted will vest over 3 years and are exercisable up to 10 years from the date of grant. Including the grant of these options, the Company will have outstanding options over approximately 9.5% of its issued share capital.

 

Notice of AGM

 

The Company also confirms it is posting its Notice of AGM ("Notice") to shareholders today, and will also publish the Notice on the Company's website. The AGM will be held on 10 June 2021.

 

For further information contact:

Andy Michuda, Executive ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (corporate finance)

Alice Lane (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gregory Coticchia

2.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 845 pence per share

80,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 80,000 options over ordinary shares of 20p pence at an exercise price of 845 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

2.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Arif Karimjee

3.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

4.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 900 pence per share

43,350

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 43,350 options over ordinary shares of 20p pence at an exercise price of 900 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Michuda

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise Price 900 pence per share

165,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 165,000 options over ordinary shares of 20p pence at an exercise price of 900 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKQBKCBKKAPD
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.